Dangerous Drug Attorneys Serving New York Residents
When your doctor prescribes a life-saving drug – particularly for a chronic condition like high blood pressure – you have every right to expect that it will work as intended. If there are serious side effects, the pharmaceutical company and any of its manufacturers have a duty to inform you about the risks, so that you can avoid sustaining a life-altering injury.
This is also the case with the prescription drug compound known as irbesartan (better known by its brand name, Avapro). However, due to negligence at multiple pharmaceutical companies, the FDA was pushed to recall dozens of irbesartan batches, after discovering that they contained toxic levels of N-nitrosodiethlamine (NDEA). NDEA is a human carcinogen that can cause organ damage and cancer when taken at consistently high levels.
If you believe that using irbesartan contributed to your cancer diagnosis or other injuries, our New York lawyers at Rheingold Giuffra Ruffo & Plotkin LLP will stand by your side. Taking swift legal action on your behalf, our team will go above and beyond to hold negligent pharmaceutical manufacturers accountable for your cancer injuries.
Call (888) 260-0473 to discuss your irbesartan case with a qualified attorney.
What Are the Risks of NDEA Exposure?
As of September 2019, there is a full voluntary recall in place for Sciegen Pharmaceuticals and other key producers of irbesartan. Because millions of Americans struggle with heightened blood pressure, this medication is a staple in many medicine cabinets, and it’s estimated that thousands of people could be at risk of NDEA exposure.
NDEA is most frequently used in complex industrial processes, including as an additive for gasoline. After extensive research, the International Agency for Research on Cancer (IARC) has classified this compound as a probable human carcinogen.
Some of the most common injuries associated with N-nitrosodiethlamine exposure include:
- Hepatic fibrosis
- Liver fibrosis and scarring
- Stomach and intestinal cancers
- Liver damage and cancer
- Blood cancers
- Esophageal cancers
- Kidney damage and cancer
What Drugs Are Included in the Irbesartan Recall?
Irbesartan is classified as an angiotensin II receptor blocker (ARB), along with related blood pressure drugs valsartan and losartan. To date, over 1,000 lots of all angiotensin II receptor blockers have been recalled by the FDA. It’s important to confirm whether your blood pressure medication was contaminated by NDEA by first checking the FDA recall list and discussing with your doctor. You should not discontinue use of your medication unless approved by a physician.
Here are a few of the largest manufacturers involved in the irbesartan recall:
- Torrent Pharmaceuticals
- Camber Pharmaceuticals
- Major Pharmaceuticals
- Prinston Pharmaceuticals
- WP Westminster Pharmaceuticals
- Teva Pharmaceuticals
A Lack of Oversight for Overseas Manufacturers
Most of the recalls for ARB drugs have been sourced back to two major overseas manufacturers: Hetero Labs and Zhejiang Huahai Pharmaceuticals, which are based in India and China respectively. By failing to regulate conditions at these manufacturers, U.S. pharmaceutical companies may be liable for cancer injuries and other conditions that stem from taking affected irbesartan.
Do you believe that you have a case? For a free evaluation, call (888) 260-0473 to contact Rheingold Giuffra Ruffo & Plotkin today.